Date: August 15, 2023
Time: 10:30 AM
Patient: Steven Chou
DOB: January 7, 1959 (65 years old)
MRN: 123456

Chief Complaint:
Mr. Chou presents for a routine checkup.

History of Present Illness:
Mr. Chou is a 65-year-old male with a past medical history of diabetes, atrial fibrillation, hypertension, and cholecystectomy. He reports no new complaints and states that his chronic conditions have been well-controlled with his current medications. He denies any chest pain, shortness of breath, palpitations, or dizziness. He also reports no abdominal pain or changes in bowel habits.

Current Medications:
1. Eliquis (Apixaban)
2. Lisinopril
3. Aspirin
4. Plavix (Clopidogrel)
5. Metoprolol
6. Simvastatin

Allergies:
No known drug allergies.

Review of Systems:
- General: No fatigue, fever, or unintentional weight changes.
- Cardiovascular: No chest pain, palpitations, or edema.
- Respiratory: No shortness of breath, cough, or wheezing.
- Gastrointestinal: No abdominal pain, nausea, vomiting, or changes in bowel habits.
- Genitourinary: No dysuria, frequency, or urgency.
- Neurological: No headaches, dizziness, or focal neurological deficits.

Physical Examination:
- Vital Signs: BP 128/78, HR 72 (regular), RR 16, Temp 98.6Â°F, SpO2 98% on room air
- General: Well-appearing, no acute distress
- HEENT: Normocephalic, atraumatic, PERRL, EOMI, no JVD
- Cardiovascular: Regular rate and rhythm, no murmurs, rubs, or gallops
- Respiratory: Clear to auscultation bilaterally, no wheezes, rales, or rhonchi
- Abdomen: Soft, non-tender, non-distended, no organomegaly, well-healed cholecystectomy scar
- Extremities: No edema, cyanosis, or clubbing
- Neurological: Alert and oriented x3, no focal deficits, normal gait and balance

Assessment and Plan:
1. Diabetes: Well-controlled. Continue current management and monitor HbA1c.
2. Atrial fibrillation: Stable on Eliquis. Continue current dose and monitor for any bleeding or thromboembolic events.
3. Hypertension: Blood pressure at goal. Continue current medications and encourage lifestyle modifications.
4. Hyperlipidemia: Continue simvastatin and monitor lipid panel.
5. Status post cholecystectomy: No complications, well-healed surgical scar.

Follow-up:
- Schedule routine follow-up in 3 months
- Obtain updated labs, including HbA1c, lipid panel, and renal function tests
- Encourage continued adherence to medications and lifestyle modifications

Signed,
Dr. [Your Name]
Senior Medical Resident